Join the “New Developments in PCNSL Treatment” webinar to learn about new research, clinical trials, specialists, ...

March 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it approved Bristol Myers Squibb's combination ...

Subscribe to our newsletter for the latest sci-tech news updates. The study, published in Nature Genetics, was co-led by Michael Green, Ph.D., professor of Lymphoma/Myeloma, and Linghua Wang, MD, Ph.D ...

Clinical trials provide patients with relapsed or treatment-resistant lymphoma access to emerging therapies, making conversations with providers essential, according to Dr. Jennif ...

This may make you think before you ink. A study of people in Sweden found that those who had gotten tattoos were 21% more likely to have subsequently been diagnosed with malignant lymphoma. And the ...

In a study published today in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of ...

VCU Massey is the first U.S. site in a global phase 2a trial for PTX-100, targeting cutaneous T-cell lymphoma. The BIPAVE-001 trial is evaluating AI-081, a PD-1 and VEGF bispecific antibody, for ...

Traits of noncancerous cells in diffuse large B-cell lymphoma (DLBCL) tumors appear to offer insight into which patients will benefit the most from chimeric antigen receptor (CAR) T-cell therapy, ...

Pulmonary lymphoma is a rare cancer in which lymphoma cells affect your lungs. It can start inside the lungs (primary) or elsewhere in the body and spread to the lungs (secondary). Lymphoma occurs ...

High glyphosate use is linked to elevated rates of non-Hodgkin lymphoma cancer, particularly in Iowa and the Upper Midwest, ...

Readers will learn how veterinary oncologists stage and treat canine lymphoma using modern multi-agent chemotherapy and ...